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Abstract
Mycobacterium tuberculosis (Mtb), possesses at least three type VII secretion systems,
ESX-1, -3 and -5 that are actively involved in pathogenesis and host-pathogen interaction.
We recently showed that an attenuatedMtb vaccine candidate (Mtb Δppe25-pe19), which
lacks the characteristic ESX-5-associated pe/ppe genes, but harbors all other components
of the ESX-5 system, induces CD4+ T-cell immune responses against non-esx-5-associ-
ated PE/PPE protein homologs. These T cells strongly cross-recognize the missing esx-5-
associated PE/PPE proteins. Here, we characterized the fine composition of the functional
cross-reactive Th1 effector subsets specific to the shared PE/PPE epitopes in mice immu-
nized with theMtb Δppe25-pe19 vaccine candidate. We provide evidence that theMtb
Δppe25-pe19 strain, despite its significant attenuation, is comparable to the WTMtb strain
with regard to: (i) its antigenic repertoire related to the different ESX systems, (ii) the
induced Th1 effector subset composition, (iii) the differentiation status of the Th1 cells
induced, and (iv) its particular features at stimulating the innate immune response. Indeed,
we found significant contribution of PE/PPE-specific Th1 effector cells in the protective
immunity against pulmonaryMtb infection. These results offer detailed insights into the
immune mechanisms underlying the remarkable protective efficacy of the live attenuated
Mtb Δppe25-pe19 vaccine candidate, as well as the specific potential of PE/PPE proteins
as protective immunogens.
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Author Summary
Mycobacterium tuberculosis (Mtb), the causative agent of human tuberculosis, is one of the
most widely spread human pathogens, responsible for more than 9.6 million of new tuber-
culosis cases and 1.5 million deaths, annually. The resurgence of pulmonary tuberculosis
in immuno-compromised patients, including HIV-co-infected populations, and increas-
ing spread of drug-resistantMtb strains are worrying. Given the estimated 2 billion cases
of latentMtb infections and the only partial efficacy of the unique, currently available
tuberculosis-vaccineMycobacterium bovis BCG (Bacille Calmette-Guerin) it is necessary
to develop improved vaccines. Here, we demonstrate that the host cellular immunity,
mediated by CD4+ T lymphocytes, specific to the “PE/PPE” families of mycobacterial anti-
gens, contribute to the protection againstMtb-induced disease. We revealed the fine com-
position of the PE/PPE-specific T cells by characterizing their effector functions and
differentiation status. We previously described a live attenuated mycobacterial strain as a
vaccine candidate that is able to induce such CD4+ T cells and which displays particular
properties at stimulating the cells of the innate immune system. These responses play a
central role in the initiation of the host defense and in the protection against tuberculosis.
Our results pave the way for further development of candidates in preclinical models of
anti-tuberculosis vaccination.
Introduction
It is estimated that two billion people are latently infected withMycobacterium tuberculosis
(Mtb), and this huge reservoir is sustaining the pan/epidemic spread of the bacterium. Due to
the relative inefficiency of theMycobacterium bovis BCG (Bacille Calmette-Guerin) vaccine in
preventing these latent infections becoming active tuberculosis (TB) disease cases in adoles-
cents and adults, new improved TB vaccines are warranted [1].
Mtb harbors five chromosomal esx clusters of highly conserved genes, which code for spe-
cialized type VII secretion systems (T7SSs), some of which are also conserved in other myco-
bacteria [2]. Some of these systems are dedicated to the export/secretion of key mycobacterial
factors and play a determinant role in host-pathogen interaction [3]. Several lines of evidence
indicate that the construction of genetically modified mycobacterial strains expressing WT
and/or mutated variants of these specialized T7SSs is a promising strategy to set up new live
attenuated TB vaccines [4–7]. We have previously shown that BCG complemented with the
esx-1 gene cluster (BCG::ESX-1), produces and secretes the 6 kDa-Early Secreted Antigenic
Target (ESAT-6, EsxA) and its partner, the 10 kDa-Culture Filtrate Protein (CFP-10, EsxB)
thereby inducing specific host immune responses (S1A and S1B Fig) that ultimately confer
improved protection against anMtb challenge in animal models, relative to the parental BCG
strain [4, 8, 9]. Sweeny and colleagues generated a recombinantMycobacterium smegmatis
strain harboring the orthologousMtb esx-3 region, which displays an improved protective effi-
cacy compared to BCG [6]. More recently, we developed an attenuatedMtb esx-5mutant, i.e.,
Mtb Δppe25-pe19, lacking the five esx-5-coded pe/ppe genes, as a promising vaccine candidate
[5, 10].
Most of the esx loci contain clusters of genes coding for members of the PE/PPE protein
families. These proteins are named after their characteristic N-terminal Pro-Glu (PE) or
Pro-Pro-Glu (PPE) motifs and are unique to the mycobacterial species. The genome of the
Mtb H37Rv strain contains 99 pe and 69 ppe genes, which most probably evolved from
ancestral esx-associated pe/ppe genes [11]. Although the function of most PE/PPE proteins
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remains to be unraveled [12–14], some of them have been demonstrated to play a role in
mycobacterial virulence, being involved in mycobacterial growth in macrophages and/or in
the mouse infection model, or in modulation of mycobacteria-mediated inhibition of pha-
gosome maturation [10, 15–21]. PE/PPE proteins display numerous repetitive sequences
and possess abundant immunogenic regions, representing a rich source of B and T cell epi-
topes [22].
The esx-5 region ofMtb (rv1782-rv1798) harbors 2 pe (pe18, 19) and 3 ppe (ppe25, 26, 27)
genes (S1A Fig). The corresponding PE18, 19, and PPE25, 26, 27 proteins are exported/secreted
through the transmembrane channel of the ESX-5 secretion apparatus, involving the ESX-Con-
served Component EccD5 [10] (S1B Fig, right). In addition, many other non-esx-5-associated
PE/PPE proteins with various degrees of sequence similarity with their esx-5-coded homologs,
are also exported/secreted via the ESX-5 system [3, 23, 24].
Our recent observation that theMtb Δppe25-pe19 strain, devoid of the five esx-5-coded
pe/ppe genes, is attenuated for growth in immune-competent and SCID mice, indicates a
role in virulence of these PE/PPE proteins [5, 10]. Importantly, as the transmembrane chan-
nel EccD5 is unaffected/intact, theMtb Δppe25-pe19 strain continues to be able to export
PE/PPE proteins, which are encoded outside the esx-5 locus. As a results, IFN-γ+ CD4+
T-cell responses are induced against a plethora of non-esx-5-coded PE/PPE homologs in
the immunized host. The involved T cells, via their high cross-reactivity, recognize esx-5-
coded PE/PPE virulence-related factors (S1B Fig, right). Therefore, due to the expression of
a functional EccD5-associated transmembrane channel and an intact ESX-5 T7SS, theMtb
Δppe25-pe19 strain shows the unique property to induce cross-reactive T-cell immunity
against the esx-5-associated PE/PPE virulence-related factors, despite their absence in this
strain [3, 5]. Epitope mapping of the PE/PPE proteins in bovines also revealed that the
highly immunogenic nature of PE/PPE immunogens is essentially driven by a substantial
degree of cross-reactivities in the elicited T cells, which results from the sequence homolo-
gies among the PE/PPE proteins [25, 26]. AnMtb eccD5 KO strain, largely deficient in PE/
PPE protein secretion, does not phenocopy the Mtb Δppe25-pe19 strain and is markedly less
protective in vaccination assays performed in the mouse model [5]. This observation
strongly suggests that immunity to PE/PPE proteins is a relevant requisite for an efficient
protection against TB.
The distribution of the functional CD4+ T-cell subsets defines the quality of the adaptive
immune response in infectious diseases including TB [27] and several reports indicate that,
at least in animal preclinical models, poly-functional CD4+ T cells mediate protection [28].
Therefore, we here characterize at the single-cell level the functionality and some aspects
of differentiation status of the cross-reactive PE/PPE-specific Th1 cells induced by Mtb
Δppe25-pe19 immunization and evaluated the contribution of PE/PPE-specific T cells in
the protective immunity against pulmonaryMtb infection in mice. These experiments pro-
vided new insights on the potential of PE/PPE proteins as protective immunogens. More-
over, the Mtb Δppe25-pe19 mutant is able to secrete ESX-1 substrates and thereby elicits
CD4+ T-cell responses against these protective immunogens. In addition to its particular
T-cell antigenicity, theMtb Δppe25-pe19 exhibits unique properties to trigger the host
innate immunity. Unlike BCG, the expression of a functionally active ESX-1 system enables
theMtb Δppe25-pe19 vaccine candidate to induce phagosomal membrane rupture and
thereby establishing a phagosome-cytosol communication inside phagocytes, a phenome-
non which has instrumental consequences on the activation of innate immunity [29–32].
These results elucidate part of the immune properties of the remarkable protective capacity
of the live attenuatedMtb Δppe25-pe19 vaccine candidate.
CD4+ T-Cell Responses to PE/PPE Protect against Tuberculosis
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Results
Fine composition of PE/PPE-specific Th1 functional subsets induced by
Mtb Δppe25-pe19 immunization
We previously identified two groups of PPE25- and PE19-derived MHC-II (I-Ab)-restricted
T-cell epitopes. One group is highly specific toMtb esx-5-encoded PE/PPE proteins and show
no homologies with other PE/PPE (S1A Table), while the second group contains epitopes
which are shared with PE/PPE homologs coded outside of esx-5 (S1B Table) [5]. Immunization
of C57BL/6 (H-2b) mice with the attenuatedMtb Δppe25-pe19 strain confirmed and extended
our previous finding that this strain is unable to induce Th1 immunity, i.e., IL-2, TNF-α, and
IFN-γ responses, against the esx-5-specific PE/PPE epitopes (S2 Fig). However, this attenuated
vaccine candidate preserved its capacity to induce Th1 immunity against the PE/PPE homologs
coded outside of esx-5, due to the expression of a functional ESX-5 transmembrane channel
associated to EccD5 [33, 34]. Such cross-reactive Th1 cells specific to the shared PE/PPE epi-
topes recognize the ESX-5-associated and virulence-related PE/PPE proteins, which are absent
in theMtb Δppe25-pe19 strain.
To delineate the effector mechanisms of PE/PPE-specific T-cell immunity, we next sub-
jected such T-cell responses to a fine analysis of the functional CD3+ CD4+ Th1 subsets by
IL-2-, TNF-α-, and IFN-γ-specific IntraCellular Staining (ICS). We first set up the strategy for
the PPE25:1-20-specific responses in the spleen ofMtb Δppe25-pe19-immunized mice (Figs 1A
and S3A and S3B). This shared epitope is representative of the identified PE/PPE peptides
listed in the S1 Table. This approach allowed the determination of the frequencies of total anti-
gen specific Th1 cytokine-producing cells (Fig 1B), as well as the definition of seven functional
subsets, which are single, double, or triple positive for the expression of these key Th1 cytokines
and their percentages compared to total CD4+ T cells (Fig 1C). Moreover, as (i) humanMtb-
specific memory CD4+ T cells are enriched in the T-cell population expressing the chemokine
receptors CCR6 and CXCR3 [35, 36], (ii) the Programmed Cell Death-1 (PD-1) marker is asso-
ciated with proliferative potential, self maintenance, IFN-γ production and protection in the
context of anti-mycobacterial immunity [37, 38], and (iii) CD27 expression is a pertinent
marker to distinguish different Th1 effector subsets [39], we also performed, together with ICS,
simultaneous surface staining with these markers in order to characterize the differentiation
status of the antigen-specific, functional Th1 subsets whose the numbers were high enough to
allow such analysis (Fig 1D). For instance, in this framework, most of the TNF-α+ single posi-
tive cells were CCR6- CXCR3- and PD1-, only a few percentages of IFN-γ+ single positive or
TNF-α+ IFN-γ+ double positive cells were CCR6+ CXCR3+ and CD27- PD1+, while the triple
positive Th1 cells contained the highest percentages of CCR6+ CXCR3+ and CD27- PD-1+
cells.
To get mechanistic insights towards the fine composition of functional Th1 cells generated
subsequent to vaccination withMtb Δppe25-pe19, we first performed such detailed compara-
tive analyses in the groups ofMtb Δppe25-pe19- orMtbWT-immunized mice (Fig 2A and 2B).
We observed that the profile of the Th1 responses specific to the different shared PE/PPE epi-
topes studied was overall similar. In theMtb Δppe25-pe19-immunized mice, different degrees
of PE/PPE-specific functional T subsets were present, which ranged from very small percent-
ages of IL-2+ TNF-α- IFN-γ- (green), predominant amounts of IL-2- TNF-α+ IFN-γ- (blue) to
intermediate percentages of IL-2- TNF-α- IFN-γ+ (yellow) single positive Th1 cells. Moreover,
IL-2+ TNF-α+ IFN-γ- (dark blue) and IL-2+ TNF-α- IFN-γ+ (white) double positive Th1 cells
were barely found, while intermediary levels of IL-2- TNF-α+ IFN-γ+ (purple) double positive
and IL-2+ TNF-α+ IFN-γ+ (red) triple positive Th1 subsets were detected. In these mice, the
cumulated numbers of IL-2- TNF-α+ IFN-γ+ or IL-2+ TNF-α+ IFN-γ+ cells specific to the
CD4+ T-Cell Responses to PE/PPE Protect against Tuberculosis
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Fig 1. Cytometric strategy used to identify different functional Th1 subsets specific to mycobacterial antigens. A) Splenocytes
from C57BL/6 mice (n = 3 per group), injected s.c. with 1 x 106 CFU/mouse ofMtb Δppe25-pe19, were stimulated in vitro with the
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totality of the shared PE/PPE epitopes can be estimated at 7.6 x 105 and 5.4 x 105 splenocytes
per mouse, respectively.
Comparison with theMtbWT-immunized mice (Fig 2B) showed that the composition of
the functional effector Th1 subsets specific to different shared PE/PPE epitopes were glob-
ally similar to those found in theMtb Δppe25-pe19-immunized group, except for the fre-
quencies of the terminally differentiated IL-2- TNF-α+ IFN-γ- (blue) cells, which decreased
for the benefit of the terminally differentiated IL-2- TNF-α- IFN-γ+ (yellow) population (Fig
2C). This finding suggests that the virulence/persistence of WTMtbmight fine-tune such
functional switches. As expected, no such Th1 subsets against the esx-5-specific PE/PPE epi-
topes were detected in theMtb Δppe25-pe19-immunized mice, in contrast to the responses
found in the WTMtb-immunized mice (S4 Fig), which displayed characteristics that were
similar between esx-5-associated and non-esx-5-associated (Fig 2B) epitopes. In theMtb
Δppe25-pe19- orMtbWT-immunized groups, we detected comparable frequencies of
CCR6+ CXCR3+ or CD27- PD-1+ cells in the TNF-α+ and IFN-γ+ single positive, TNF-α+
IFN-γ+ double positive and IL-2+ TNF-α+ IFN-γ+ triple positive functional Th1 subsets, spe-
cific to the representative PPE25:1–20 shared epitope (Fig 3A and 3B). These results showed
that the differentiation status of the functional Th1 subsets were very similar subsequent to
immunization with theMtbWT- orMtb Δppe25-pe19.
Therefore, compared to the WTMtb, theMtb Δppe25-pe19 strain induces a similar range of
differentiated cross-reactive Th1 effectors specific to the shared PE/PPE epitopes, which also
recognize the ESX-5-associated PE/PPE virulence-related factors, with very slight differences
in the proportions of TNF-α+ or IFN-γ+ single positive cells.
ESX-1-linked immunogenic properties of theMtb Δppe25-pe19 strain
One of the most relevant properties of theMtb Δppe25-pe19 candidate vaccine is its capacity to
secrete ESX-1 virulence determinants ESAT-6 and CFP-10 [40], while displaying a strongly
attenuated phenotype relative to parental H37RvMtb [5, 10]. Virulence comparison test in
SCID mice showed thatMtb Δppe25-pe19 was slightly more virulent compared to BCG Danish
(S5 Fig). TheMtb Δppe25-pe19 attenuation profile resembles that of BCG strains belonging to
the DU2 IV group (BCG Phipps, BCG Frappier, BCG Pasteur, BCG Tice), which also showed
somewhat elevated virulence relative to BCG Danish in a recent comparative study of 13 BCG
strains [41, 42]. We further characterized the fine-tuned Th1 immunity specific to ESAT-6 in
Mtb Δppe25-pe19- or WTMtb-immunized mice. Compared to the PE/PPE-specific responses,
the levels of ESAT-6-specific Th1 cytokine released by splenocytes were generally stronger in
both groups (S2 Fig). The distribution of ESAT-6-specific Th1 subsets (Fig 4A–4C) was distinct
from that of PE/PPE-specific Th1 subsets (Fig 2A–2C). Comparatively, the ESAT-6-specific
response was characterized by decreased percentages of IL-2- TNF-α+ IFN-γ- (blue) single pos-
itive cells for the benefit of IL-2- TNF-α+ IFN-γ+ (purple) double positive cells. This suggests
that the distribution of Th1 subsets can vary as a function of the antigen specificity following
vaccination, probably linked—among others—to the different level of expression and secretion
patterns of these different antigens. In addition to ESAT-6- and CFP-10-specific responses,
PPE25:1–20 peptide at 4 weeks p.i., prior to surface and intracellular staining to detect single, double or triple positive antigen-specific Th1
cells. B) Percentage of cells producing any of the Th1 IL-2/TNF-α/IFN-γ cytokines (CTK) compared to total CD4+ T splenocytes. C)
Definition of antigen-specific Th1 effector subsets as a function of their IL-2/TNF-α/IFN-γ expression and their percentages compared to
total CD4+ T splenocytes. Means ± SD are standard deviations. D) Surface expression of CCR6, CXCR3, CD27 and PD-1 as analyzable in
TNF-α+ or IFN-γ+ single positive, TNF-α+ IFN-γ+ double positive or IL-2+ TNF-α+ IFN-γ+ triple positive, antigen-specific functional Th1
subsets. Data are representative of two independent experiments. See furthermore S3 Fig.
doi:10.1371/journal.ppat.1005770.g001
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Δppe25-pe19-immunized mice mounted strong T-cell responses against EspC (Rv3615c),
another ESX-1 substrate (Fig 4D), which is also considered as a protective immunogen [43].
In addition to Th1 cells specific to ESX-1/ESX-5-related antigens, other properties of the
Mtb Δppe25-pe19 strain, including ESX-1-mediated triggering of innate immunity [29–32, 44,
45], may also take part in the improved protective capacity of this strain. A major characteristic
feature of ESX-1-proficient mycobacteria is their capacity to induce phagosomal rupture in
infected host cells [46, 47], which is followed by the activation of numerous pathways of innate
immune responses. These include the cytosolic translocation of mycobacterial DNA, detected
by the host cyclic GMP-AMP synthase (cGas) and activation of the STING/TBK/IRF3 path-
way. This process leads to the production of IFN-β, as well as the activation of Absent In Mela-
noma 2 (AIM2) inflammasome/caspase-1 pathway, which contributes to the release of active
IL-1β [29–32, 44, 45] and IL-18-mediated noncognate IFN-γ production [48]. Using a FRET
method, based on the accessibility of the intrinsic β-lactamase activity of the phagocytosed
mycobacteria to the host cytosol [46, 47], we demonstrated that theMtb Δppe25-pe19 strain, in
contrast to BCG, is able to induce such phagosomal rupture (Fig 4E). Unlike BCG, theMtb
Δppe25-pe19 strain induced secretion of IFN-β by the infected macrophages, albeit at a lesser
extent than the virulentMtbWT strain (Fig 4F). Similarly, theMtb Δppe25-pe19 strain induced
significantly more IL-1β release than the BCG strain (Fig 4G). These important properties may
also take part in the previously reported improved protective capacity of theMtb Δppe25-pe19
strain in comparison to BCG [5].
Induction of PE/PPE-specific Th1 cells by peptide immunization
By comparative immunological investigation of theMtb Δppe25-pe19 andMtb eccD5 KO
strains, we previously showed that the former induces robust cross-reactive CD4+ T cells
against ESX-5-associated PE/PPE and also against a plethora of other PE/PPE antigens, while
the latter, which is largely deficient in PE/PPE export/secretion, induces no T-cell response to
the panel of PE/PPE epitopes that we selected (S1 Table) [5]. Consistent with our previous
observations [5], theMtb Δppe25-pe19 strain displayed a better protective potential than the
Mtb eccD5 KO strain (Fig 5A). Based on this observation, we hypothesized that Th1 immunity
to PE/PPE antigens may contribute to the cellular mechanisms of TB protection. To experi-
mentally test this hypothesis and to directly evaluate the contribution of PE/PPE-specific Th1
cells in the protection, we established an immunization protocol to induce PE/PPE-specific
Th1 responses, not with the live attenuatedMtb Δppe25-pe19 vaccine, with complex multiface-
ted immunological properties (Fig 4), but by use of PE/PPE-derived synthetic peptides (S1
Table).
C57BL/6 mice (n = 3 per group) were immunized s.c. twice at a 10-day interval with each of
the individual PE/PPE-derived peptides. As adjuvant TLR9 agonist CpG oligodeoxynucleotide,
associated with the liposomal transfection reagent DOTAP (N-[1-(2,3-DioleOyloxy)]-N,N,
N-TrimethylAmmonium Propane methylsulfate) was used. At day 10 after the second injec-
tion, antigen-specific production of IL-2, TNF-α, and IFN-γ by CD4+ T splenocytes was readily
Fig 2. Comparative study of the functional Th1 effector subsets specific to shared PE/PPE epitopes
subsequent to immunization with theMtb Δppe25-pe19 or WT strain. Frequencies of different Th1 cytokine-
producing splenic CD4+ T effectors, at 4 weeks p.i., in C57BL/6 mice (n = 5 per group) injected s.c. with 1 x 106
CFU/mouse of theMtb Δppe25-pe19 (A) or theMtbWT strain (B) and stimulated in vitro with 10 μg/ml of
individual shared PPE25 and PE19 peptides. C) Means ± SD of the frequencies of each Th1 subset, as
cumulated for all the studied shared peptides, compared between theMtb Δppe25-pe19- and theMtbWT-
immunized groups. NS = not significant, *, ** = statistically significant, as determined by Mann-Whitney test,
p<0.05 or p<0.005, respectively. The results are representative of two independent experiments. See furthermore
S4 Fig.
doi:10.1371/journal.ppat.1005770.g002
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Fig 3. Comparative study of the differentiation status of the antigen-specific functional Th1 subsets in
Mtb Δppe25-pe19- orMtbWT-immunized mice. Splenocytes from the immunized mice were stimulated
with the representative PPE25:1–20 synthetic peptide as described in Materials and Methods, stained for the
surface differentiation markers, and then processed for ICS specific to Th1 cytokines. Percentages of
CXCR3+ CCR6+ (A) or PD-1+ CD27- (B) cells were determined, as detailed in the Fig 1D, subsequent to
gating on different functional Th1 subsets. Results are means ± SD of experimental duplicates.
doi:10.1371/journal.ppat.1005770.g003
CD4+ T-Cell Responses to PE/PPE Protect against Tuberculosis
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detected (Fig 5B). However, for all of the epitopes, the amounts of these cytokines produced by
the splenocytes of the peptide-immunized mice were weaker than the levels produced by their
mycobacteria-immunized counterparts (S2 Fig). Results from an ICS assay performed in mice
immunized with each peptide (Fig 6A–6C) showed increased frequencies of IL-2+ TNF-α-
IFN-γ- (green) single positive, IL-2+ TNF-α+ IFN-γ- (dark blue) double positive and IL-2+
TNF-α+ IFN-γ+ (red) triple positive Th1 cells for each epitope, compared to the frequencies
observed in theirMtb Δppe25-pe19-immunized counterparts (Fig 2C). Moreover, the termi-
nally differentiated TNF-α+ single positive cells constituted the major Th1 cell subset in these
peptide-immunized mice (Fig 6A–6C). The PE/PPE-specific Th1 cells induced by peptide or
Mtb Δppe25-pe19 immunization notably displayed the following functional and phenotypic
features: (i) Fluorescence Intensities (MFI) of the ICS staining for each Th1 cytokine, which are
proportional to the amounts of cytokine production per cell (Fig 6D), and (ii) the differentia-
tion status of the TNF-α+ and IFN-γ+ single positive, TNF-α+ IFN-γ+ double positive and IL-
2+ TNF-α+ IFN-γ+ triple positive functional Th1 subsets, in terms of CCR6, CXCR3, CD27
and PD-1 surface expression (S6 Fig and Fig 3).
Contribution of PE/PPE-specific Th1 responses to anti-mycobacterial
protection
We further evaluated directly the contribution of the anti-PE/PPE poly-specific Th1 cells, sys-
tematically and locally induced by use of the PE/PPE-derived synthetic peptides, in the protec-
tion against virulentMtb. For a better understanding of the protective adaptive immunity in
terms of fine specificity of T cells, we compared the protective potential of Th1 cells either spe-
cific to the esx-5-associated PE/PPE epitopes or to the shared epitopes. C57BL/6 (n = 6 per
group) mice were vaccinated according to the protocol schematized in the Fig 7A with individ-
ual PE/PPE peptides (for prior immune response study) or mixtures of such peptides (for pro-
tection studies). PE/PPE peptides which harbor esx-5-specific or shared epitopes were
formulated in CpG(DOTAP). Moreover, since previous works demonstrated that mucosal
local immunity and the homing of effector T cells from the lung vasculature to the parenchyma
is crucial for the pulmonary TB protection [49–52], the mice were also boosted i.n. with homol-
ogous PE/PPE peptides 10 days before the challenge. In the pulmonary CD4+ T-cell compart-
ment of these mice, we detected in ex vivo tests increased percentages of CD27- CD62L-,
CCR6+ CXCR3+, CD27- PD-1+ (Fig 7B), as well as CD44hi (S7A Fig) cells, representing a hall-
mark of migratory antigen-specific poly-functional effector T cells of the peripheral tissues.
The protective potential of immunization with the peptide mixtures was compared to that
of vaccination with BCG 1173P2 Pasteur strain. At day 40, vaccinated mice or untreated con-
trols were aerosol infected with the virulentMtbH37Rv strain, delivered at dose of 200
CFU/lungs. At day 70, determination of the mycobacterial loads in the lungs (Fig 7C) and
Fig 4. Immunogenic features of theMtb Δppe25-pe19 strain linked to its functional ESX-1 secretion system. Frequencies of
different Th1 cytokine-producing splenic CD4+ T effectors, at 4 weeks p.i., in C57BL/6 mice (n = 5 per group) immunized theMtb
Δppe25-pe19 (A) or theMtbWT strain (B) and stimulated in vitro with 10 μg/ml of the ESAT-6:1–20 peptide. C) Means ± SD of the
frequencies of each Th1 subset, compared between theMtb Δppe25-pe19- and theMtbWT-immunized mice. NS = statistically not
significant as determined by Mann-Whitney test. The immunized mice were those studied for PE/PPE-specific responses in the Fig
2. D) C57BL/6 mice (n = 2 per group) were immunized s.c. with 1 x 106 CFU/mouse of BCG,Mtb Δppe25-pe19 orMtbWT strain. At
4 weeks p.i., IFN-γ T-cell responses were studied against ESAT-6, CFP-10 and EspC ESX-1 antigens. EspC:40–54 is an
immunodominant I-Ab-restricted epitope that we recently identified by epitope mapping. E) Phagosomal rupture induced in
differentiated THP-1 macrophages, infected at MOI of 1, with theMtb Δppe25-pe19 strain as compared to theMtbWT and to BCG
Pasteur, as determined at day 3 post infection by the CCF-4-based FRET inhibition assay. In parallel, IFN-β (F) and IL-1β (G) were
quantified in the culture supernatants of these infected THP-1 cells at 24 h post infection. *, **, *** = statistically significant, as
determined by OneWay ANOVA test with Tukey’s correction for multiple comparisons, p<0.05, p<0.005 or p<0.001, respectively.
doi:10.1371/journal.ppat.1005770.g004
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Fig 5. Comparative protective effects ofMtb Δppe25-pe19 orMtb eccD5 KO strain and induction of ESX-5-related PE/
PPE specific T-cell responses by immunization with synthetic peptides. A) C57BL/6 mice (n = 6 per group), left unvaccinated
or immunized s.c. with 1 x 106 CFU/mouse ofMtb Δppe25-pe19 orMtb eccD5 KO strain, were challenged at 4 weeks p.i. via
aerosol route with 200 CFU/mouse ofMtb H37RvWT strain. One month post-challenge, the mycobacterial loads were
determined in the lungs and spleen of individual mice. NS = not significant, *, **, ***, **** = statistically significant, as
determined by OneWay ANOVA test with Tukey’s correction for multiple comparisons, p<0.05, p<0.005, p<0.001 or p<0.0001,
respectively. B) IL-2, TNF-α and IFN-γ production, detected in the culture supernatants of splenocytes frommice (n = 3 per group),
CD4+ T-Cell Responses to PE/PPE Protect against Tuberculosis
PLOS Pathogens | DOI:10.1371/journal.ppat.1005770 July 28, 2016 12 / 27
spleen (Fig 7D) showed that immunization with the mixtures of PE/PPE peptides, either spe-
cific to the esx-5 region or shared with other homologs, induced a significant protection, which
was only partially due to the effect of the adjuvant alone.
BCG has an intact ESX-5 secretion system and induces T-cell immunity against all the
selected PE/PPE epitopes (S7 Fig). We thus evaluated the effect of BCG priming and PE/PPE
boosting on immune responses and TB protection following immunization with PE/PPE epi-
topes, as detailed in the Fig 8A In the lungs of these mice, as determined ex vivo, we observed
increased percentages of CD27- CD62L-, CCR6+ CXCR3+, CD27- PD-1+ (Fig 8B), and CD44hi
(S7B Fig) cells, within the CD4+ T-cell compartment, as well as increased total numbers of
CD4+ T cells (S8C Fig). BCG priming followed by PE/PPE boosting significantly improved the
control of mycobacterial growth in the lungs (Fig 8C) and limited the mycobacterial dissemina-
tion to the spleen (Fig 8D).
Altogether, our results highlight the protective capacity of these PE/PPE proteins as immu-
nogens and unravel part of the immune mechanisms of the remarkable protective property of
theMtb Δppe25-pe19 vaccine candidate.
Discussion
In the present study, we demonstrated that PE/PPE-specific Th1 cells contribute to the cellular
protective immune mechanisms developed by the live attenuatedMtb Δppe25-pe19 TB vaccine
candidate that we recently generated [5, 10]. Secretion or export to the bacterial cell-envelop is
a prerequisite for most mycobacterial antigens to access the antigen presentation machinery
inside the host innate immune cells and for specific detection by effector CD4+ T cells [3]. A
large number of PE/PPE proteins are exported/secreted via the ESX-5 T7SS [24], although a
few PE/PPE proteins might also be handled via the SecA general secretory pathway [53]. The
biological activities of PE/PPE proteins are thus likely linked to their cell surface-associated or
extracellular localization, which may also explain their notable immunogenicity [14, 54–58]. It
has been proposed that the duplication and random insertion of the pe/ppe genes throughout
theMtb genome may have led to their transcriptional control by a random assortment of unre-
lated promoters and regulators, which could result in substantial degrees of variability in their
expression profiles during different phases of infection [59]. Besides, there exist compelling
sequence homologies among the PE/PPE members resulting from gene duplication. This con-
text may lead to the consecutive availability of groups of PE/PPE epitopes during various
phases of infection, despite the variability in the expression profiles of the PE/PPE members
from which they derive. Such properties may contribute to the interest of these proteins in the
protective immunity against chronic mycobacterial infections.
The attenuatedMtb Δppe25-pe19 strain is deficient only in five PE/PPE proteins, i.e.,
PPE25-27 and PE18-19, which are coded inside the esx-5 region [5, 10]. However, due to the
intact secretion machinery of the ESX-5 system, theMtb Δppe25-pe19 strain has preserved the
capacity to export/secrete substantial numbers of other PE/PPE proteins encoded elsewhere in
theMtb genome (S1B Fig, right) [24]. Immunization with theMtb Δppe25-pe19 strain thus
induces T-cell immunity against these PE/PPE proteins, including the non-esx-5-associated
members, which display compelling sequence homologies with the missing esx-5-coded PE/
PPE antigens [5]. Therefore, the antigenic repertoire of theMtb Δppe25-pe19 strain remains
virtually comparable to that of the WTMtb strain despite its strongly attenuated virulence
phenotype.
immunized with individual synthetic PE/PPE peptides formulated in CpG(DOTAP) at 10 days p.i. Error bars represent ± SD. The
results are representative of two independent experiments.
doi:10.1371/journal.ppat.1005770.g005
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Immune correlates of TB protection remain elusive. So far, in human, there is no consensus
whether the induction of poly-functional Th1 cells and the distribution of the various Th1 sub-
sets are markers of either active TB disease or of protective immunity in latent TB infection
[60–62]. Single positive IL-2+ Th1 cells are usually central memory T cells, able to proliferate
and differentiate to effector memory and/or effector cells, while single positive IFN-γ+ or TNF-
α+ Th1 cells are terminally differentiated, not proliferative and short-lived populations [28].
The accumulation of TNF-α+ single positive cells is considered as predictor of diagnosis of
active TB [63]. Consistently, it is admitted that in chronic diseases like TB, the continuous anti-
genic stimulation of T cells leads to the loss of both memory potential and poly-functionality,
which results in terminally differentiated T cells that only produced IFN-γ or TNF-α. In mice,
poly-functional IL-2+ TNF-α+ IFN-γ+ Th1 responses against prominent mycobacterial immu-
nogens cells display a positive correlation with proliferative capacity, indicative of their effector
capacity. In the mouse model, these cells are considered the most reliable parameter able to
control the growth and dissemination ofMtb in vivo [27]. Here, we showed that immunization
of mice with theMtb Δppe25-pe19 strain induces marked IL-2- TNF-α+ IFN-γ+ double positive
and IL-2+ TNF-α+ IFN-γ+ triple positive poly-functional Th1 effector cells specific to a panel
of PE/PPE epitopes. Notably, most PE/PPE-specific triple positive Th1 splencoytes in theMtb
Δppe25-pe19-immunized mice exhibited a CXCR3+ CCR6+ PD-1+ phenotype, as a hallmark of
effector memory and protective T-cell population. [35–38]. Expression of the PD-1 inhibitory
receptor by Th1 cells has been recently shown to be of utmost important in the TB protection
via the negative regulation of IFN-γ-over-expressing CD4+ T cells [38]. We further compared,
in mice immunized with theMtbWT or theMtb Δppe25-pe19 strain, the profiles of functional
Th1 subsets specific to PE/PPE epitopes, which are either highly specific to the esx-5 region or
shared with PE/PPE homologs coded outside of esx-5 [5]. As expected, theMtb Δppe25-pe19
strain does not induce T-cell responses against the first group of epitopes. However, the
responses were comparable in theMtb Δppe25-pe19- orMtbWT-immunized groups against
the shared PE/PPE epitopes in terms of their fine composition of Th1 effector subsets and their
differentiation status. Therefore, despite its attenuation, theMtb Δppe25-pe19 strain generates
bi- and poly-functional Th1 cells, which recognize the PE/PPE antigens that it lost, with the
diverse Th1 subsets distributed comparably toMtbWT.
We further demonstrated that PE/PPE-specific Th1 responses contribute actively to the
anti-TB immunity. This is shown by the induced Th1 cells, as well as the recruitment and acti-
vation of effector T cells in the lungs, following systemic and local immunization of mice with
selected PE/PPE epitopes, formulated in CpG(DOTAP) adjuvant. Importantly, the mycobacte-
rial PE/PPE epitopes, either esx-5-sepcific, with no homologies with other PE/PPE proteins, or
shared with PE/PPE homologs coded outside of esx-5, induce similar levels of protection.
Therefore, it can be proposed that the shared surrogate PE/PPE homologs in theMtb
Δppe25-pe19 strain compensate for the loss of the esx5-specific epitopes. In addition, booster
immunization with such PE/PPE epitopes in BCG-primed individuals significantly improved
the protection. These results thus show that such PE/PPE proteins represent potent immuno-
gens to be included in TB subunit vaccines or as boosters.
Fig 6. Th1 effector subsets specific to PE/PPE epitopes subsequent to vaccination with individual synthetic
peptides. Percentage and composition of CD4+ T splenic effectors of C57BL/6 mice (n = 3 per group) vaccinated with
individual synthetic peptides containing PE19- and PPE25-derived epitopes, either highly specific to esx-5 (A) or shared by
other PE/PPE proteins (B) coded outside esx-5 region. C) Means ± SD of the frequencies of each Th1 subset, as cumulated
for all the studied peptides, in the immunized groups. (D) The geometric Mean Fluorescence Intensities (MFI) of intracellular
IL-2, TNF-α or IFN-γ in each of the antigen-specific functional Th1 subsets, as determined in the spleen of mice immunized
withMtb Δppe25-pe19 or with PPE25:1–20, as a representative peptide. The results are representative of two independent
experiments.
doi:10.1371/journal.ppat.1005770.g006
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Despite its attenuated phenotype, theMtb Δppe25-pe19 strain remains able to induce Th1
responses against ESX-1-associated virulence factors, including at least ESAT-6, CFP-10 and
EspC, known as protective immunogens [40, 43, 64–69]. Moreover, the presence of a func-
tional ESX-1 system preserves the capacity of theMtb Δppe25-pe19 strain at inducing ruptures
in the phagosomal membrane inside the host phagocytes. The phagosomal rupture results in a
phagosome-cytosol communication, leading to the release of mycobacterial compounds,
including the extracellular mycobacterial DNA, to the host cytosol. Mycobacterial DNA is then
sensed by cGas and ultimately activates IFN-β gene transcription [29–32]. We showed that
Mtb Δppe25-pe19- (but not BCG-) infected macrophages secrete IFN-β. On the other hand,
detection of mycobacterial DNA by the cytosolic AIM2 inflammasome increases caspase-1
activation and contributes significantly to the release of mature IL-1β [70]. It has been shown
that following the ESX-1-dependent phagosomal rupture, the ESX-5 T7SS, via still unknown
mechanisms, activates inflammasome and caspase-1, which results in IL-1β release [71]. It is
noticeable that the ESX-5 mutantMtb Δppe25-pe19 strain is only deficient in five PE/PPE esx-
5-associated proteins, and still harbors a functional ESX-5 system. This property seemingly
confers to this strain an increased capacity to activate inflammasome and IL-1β release. Even
though the role of the type-I IFN in the induction of protective immune responses remains elu-
sive, that of IL-1β is instrumental in the anti-mycobacterial host defense [72]. Collectively, the
immunological fine characterization presented in this study emphasizes the unique properties
ofMtb Δppe25-pe19 strain to stimulate host immunity in terms of both antigenic repertoire
and innate immune responses.
While the safety profile for theMtb Δppe25-pe19 strain in SCID or immune-competent
mice [5, 10] is within the range of BCG strains [41, 42], work is in progress to introduce a sec-
ond attenuating gene deletion in order to satisfy the Geneva Consensus recommendations for
novel live TB vaccines [73]. This process shall provide anMtb Δppe25-pe19 derivative with
increased security and safety, but unaffected advantageous immunological profile, to be used as
a new veterinary or human TB vaccine.
Materials and Methods
Mycobacteria
Mtb Δppe25-pe19 [10] andMtbWTH37Rv strains were grown in Dubos broth, complemented
with Albumine, Dextrose and Catalase (ADC, Difco, Becton Dickinson, Le Pont-de-Claix,
France). The bacterial contents were determined by ODmeasurement at 600 nm. CFU were
counted on Middlebrook 7H11 solid Agar medium after 18 days of incubation at 37°C. All
experiments with pathogenic mycobacteria were performed in an L3 protection level labora-
tory, in accordance with the hygiene and security recommendations of Institut Pasteur.
Fig 7. Evaluation of the protective effect of PE/PPE immunization againstMtb infection. A) Immunization
regimen with PE/PPE-derived peptides. C57BL/6 mice (n = 6 per group) were injected with PBS or vaccinated
twice s.c. at 10-days interval with individual or mixtures of selected PE/PPE-derived peptides, formulated in CpG
(DOTAP). Peptide-immunized mice were boosted with the same individual or mixted PE/PPE peptides, formulated
in CpG(DOTAP), via i.n. route at day 30. B) Expression of T-cell activation/migration/differentiation markers by the
lung CD3+ CD4+ T cells in PE/PPE-immunized or the control mice, as studied ex vivo at day 40. See furthermore
S8A Fig. C-D) Protective potential of such immunization against an aerosol challenge with virulentMtb. Mice were
immunized according to (A) with PE/PPE peptide mixtures of (i) esx-5-specific epitopes (PE19:1–18, PPE25:281–
295 and PPE25:236–255 peptides), or (ii) shared epitopes (PE19:34–51, PPE25:1–20 and PPE25:201–215
peptides). They were then challenged at day 40 via aerosol route with 200 CFU/mouse ofMtb H37RvWT strain.
One month post-challenge, the mycobacterial loads were determined in the lungs (C) and spleen (D) of individual
mice. NS = not significant, *, **, ***, **** = statistically significant, as determined by OneWay ANOVA test with
Tukey’s correction for multiple comparisons, p<0.05, p<0.005, p<0.001 or p<0.0001, respectively.
doi:10.1371/journal.ppat.1005770.g007
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Peptides
The synthetic peptides which contain MHC-II-restricted antigenic epitopes were synthesized
by PolyPeptide Group (Strasbourg, France), reconstituted in H2O containing 5% dimethyl sulf-
oxide (DMSO) (Sigma-Aldrich, France) and stored at -20°C.
Mice and immunizations
Six-to-eight week-old female C57BL/6 (H-2b) mice (Janvier, Le Genest-Saint-Isle, France) were
immunized by s.c. injection, at the base of the tail, of 1 x 106 CFU/mouse ofMtb Δppe25-pe19
orMtbWT strains in 200 μ1 volume. Immunizations with peptides were performed by two s.c.
injections at a 10-day interval, with 100 μg/mouse of individual peptide, formulated with 30 μg
of CpG 1826 oligodeoxynucleotides as adjuvant (Sigma-Aldrich, France), 60 μl of liposomal
transfection reagent DOTAP (N-[1-(2,3-DioleOyloxy)]-N,N,N-TrimethylAmmonium Pro-
pane methylsulfate, Roche, France) and 10 μl of Opti-MEM (Life Technologies, France) in a
final volume of 200 μl. The liposomal transfection reagent DOTAP optimizes the adjuvant
effect of CpG by conducting it to the endosomal sites where the intracellular TLR-9 receptor is
localized.
Ethics statement
Studies in immunocompetent mice were performed in agreement with guidelines of the Euro-
pean and French guidelines (Directive 86/609/CEE and Decree 87–848 of 19 October 1987),
after approval by the Institut Pasteur Safety, Animal Care and Use Committee and under local
ethical committee protocol agreement # CETEA 2013–0036 and CETEA 2012–0005. Analysis
of virulence in SCID mice was approved by the UK Home Office (HO) regulations for animal
experimentation which requires a HO-approved licence and approval from local ethical com-
mittees of Public Health England, Porton Down (Licence number PPL30/2704) and London
School of Hygiene and Tropical Medicine (LSHTM) Animal Welfare and Ethical Review
Board (Authorization # 70/6934).
T-cell cytokine secretion assay
Splenocytes from immunized mice were cultured in flat-bottom 96-well plates (TPP, Den-
mark) at 1 x 106 cells per well in HL-1 medium (Biowhittaker, Lonza, France), complemented
with 2 mMGlutaMax (Invitrogen, Life Technologies, France), 5 x 10−5 M β-mercaptoethanol,
100 U/ml penicillin and 100 μg/ml streptomycin (Sigma-Aldrich, France) in the presence of
10 μg/ml of individual peptides. After 12, 48 and 72 hours of incubation at 37°C and 5% CO2,
IL-2, TNF-α and IFN-γ were respectively quantified in the culture supernatants by ELISA as
previously described [8]. Monoclonal antibodies (mAbs) specific to IL-2 (clone JES6-1A12 for
coating and clone JES6-5H4 for detection) or IFN-γ (clone AN-18 for coating and clone R4-
Fig 8. Improved protection with PE/PPE boosting in BCG-primedmice. A) BCG priming and boosting protocol with
PE/PPE-derived peptides. C57BL/6 mice (n = 6 per group) were injected with PBS or immunized s.c. with BCG. Two
months later, mice were vaccinated twice s.c. at 10-days interval with individual or mixtures of PE/PPE-derived peptides
formulated in CpG(DOTAP), followed by an i.n. administration of the same peptides. B) Expression of T-cell activation/
migration/differentiation markers by the lung CD3+ CD4+ T cells of BCG-primed, PE/PPE-boosted mice at day 90. See
furthermore S8B and S8C Fig. Mice were challenged 10 days after the last immunization (day 90) with 200 CFU/mouse
ofMtb H37RvWT strain via aerosol, as determined by day 1 post challenge by CFU counting in the lungs. One month
post challenge, the mycobacterial loads were determined in the lungs (C) and spleen (D) of individual mice. NS = not
significant, *, **, ***, **** = statistically significant, as determined by OneWay ANOVA test with Tukey’s correction for
multiple comparisons, p<0.05, p<0.005, p<0.001 or p<0.0001, respectively.
doi:10.1371/journal.ppat.1005770.g008
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6A2 for detection) were from BD Pharmingen (Le pont-de-Claix, France). Anti-TNF-αmAbs
(clone 1F3F3D4 for coating and clone XT3/XT22 for detection) were from eBioscience.
Cytometry
Single-cell suspensions from spleen of immunized mice were obtained by tissue dissociation,
homogenization and passage through 100 μm-pore filter. Cells were cultured at 7.5 x 106 cells/
well in the presence of 1 μg/ml anti-CD28 (clone 37.51) and 1 μg/ml of anti-CD49d (clone
9C10-MFR4.B) mAbs (BD Pharmingen) together with 1 x 106 cells/well syngenic bone-marrow
dendritic cells, loaded with 10 μg/ml of homologous or control peptide during 1h, followed by
5h of incubation with Golgi Plug (BD Pharmingen), according to manufacture’s instructions.
Cells were then harvested, washed twice with PBS containing 3% Fetal Bovine Serum (Invitro-
gen, Life Technologies, France) and 0.1% NaN3 (FACS buffer) and incubated for 15 minutes at
4°C with FcγII/III receptor blocking anti-CD16/CD32 (clone 2.4G2) mAb. Cells were then
incubated for 25 minutes with appropriate dilutions of AlloPhycoCyanin (APC)-eFluor780--
anti-CD3ε and PB-anti-CD4 mAbs (BD Pharmingen) at 4°C and sheltered from light. The
stained cells were washed twice in FACS buffer, permeabilized by use of Cytofix/Cytoperm kit
(BD Pharmingen). Cells were then washed twice with PermWash 1X buffer from the Cytofix/
Cytoperm kit and incubated with appropriate dilutions of PerCP-Cyanine5.5-anti-IL-2 (clone
JES6-5H4, eBioscience), PE-anti-TNF-α (clone 554419, BD Pharmingen), and Alexa Fluor647-
anti-IFN-γ (clone XMG1.2, eBioscience) mAbs during 30 minutes at 4°C. Appropriate staining
with control Ig isotypes was performed in parallel. Cells were subsequently washed twice in
PermWash buffer, once in FACS buffer and then fixed with 4% paraformaldehyde overnight at
4°C. When indicated, cells were stained at the surface, either ex vivo or after in vitro simulation
before ICS, with a cocktail of (APC)-eFluor780-anti-CD3ε, PB-anti-CD4, PE-Cy7-anti-CCR6
(Sony Biotechnology), FITC-anti-CXCR3 (eBioscience), FITC-anti-PD-1 (Biolegend) and
PE-Cy7-anti-CD27 (BD Pharmingen) mAbs. We preliminarily checked that the expression of
CCR6, CXCR3, CD27 and PD-1 markers did not change during the short in vitro stimulation
required for ICS.
To study the phenotype of the pulmonary T cells, lungs were first disaggregated by treat-
ment with 400 U/ml type IV collagenase and DNase I (Roche). Following a 45-min incubation
at 37°C, single-cell suspensions were prepared by use of GentleMacs (Miltenyi) and passage
through 100-μm nylon filters (Cell Strainer; BD Falcon). Cell suspensions were then enriched
in lymphocytes by 20-min centrifugation at 3000 rpm at RT on Ficoll gradient medium (Lym-
pholyte M, Cedarlane Laboratories). The cells were then washed twice and stained with a cock-
tail of (APC)-eFluor780-anti-CD3ε, PB-anti-CD4, PE-anti-CD27, PE-Cy7-anti-CD62L, PE-
anti-CD44 (eBioscience) and FITC-anti-CD45RB (eBioscience) mAbs in the presence of FcγII/
III receptor blocking mAb. The stained cells were then fixed with 4% paraformaldehyde. The
cells were acquired in an LSR Fortessa flow cytometer system by use of BD FACSDiva software
(BD Bioscience). Data were analyzed using FlowJo software (Treestar, OR, USA).
Phagosomal rupture assay and innate immune response analysis
PMA-differentiated THP-1 cells were infected withMtbWT orMtb Δppe-25-pe19 strains at
MOI of 1. At day 3 p.i., the phagosomal rupture was assessed by Fluorescence Resonance
Energy Transfer (FRET) assay as previously described [47]. Briefly, cells were stained with
8 μMCCF-4 (Cephalosporin core linking a 7-hydroxyCoumarin to a Fluorescein) (Invitrogen)
in EM buffer (120 mMNaCl, 7 mM KCl, 1.8 mM, CaCl2, 0.8 mMMgCl2, 5 mM glucose and
25 mMHepes, pH 7.3) complemented with 2.5 μM probenecid, during 1h at room tempera-
ture. Cells were then washed in PBS and stained with APC-anti-CD11b (BD Pharmingen)
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mAb in FACS buffer. Cells were then fixed with 4% paraformaldehyde overnight at 4°C and
were analyzed in a CyAn cytometer (Beckman Coulter, France). Human IL-1β and IFN-β were
quantified in the culture supernatants of these infected THP-1 cells at 24h p.i. by use of
(DY201-05, R&D Systems) and (41410, PBL Assay Science) kits, respectively.
Protection assays
Six-to-eigth week-old female C57BL/6 mice were left untreated or were immunized s.c. with 1
x 105 CFU/mouse of BCG (1173P2 Pasteur strain) at day 0 or immunized s.c. twice at days 10
and 20, with 50 μl of each PE/PPE-derived peptide of interest, 30 μg of CpG, 60 μl of DOTAP
and 10 μl Opti-MEM contained in 200 μl/mouse. At day 30, peptide-immunized mice received
via intra-nasal route under anesthesia 20 μg of each PE/PPE-derived peptide of interest, 20 μg
of CpG, 10 μl of DOTAP and 3 μl Opti-MEM contained in 20 μl/mouse. For anesthesia, mice
received i.p. 100 μl/mouse of suspension containing weight-adapted quantities of Imalgène1000
(Kétamine, i.e., 100 mg/kg, Merial, France) and Rompun 2% (Xylazine solution, 10 mg/kg,
Bayer, Germany), prepared in physiological solution. Mice were challenged 10 days after the
last immunization by use a homemade nebulizer via aerosol. Five ml of a suspension contain-
ing 2.5 x 106 CFU/ml ofMtbH37RvWT strain were aerosolized to reach an inhaled dose of
200 CFU/mouse, as determined by day 1 p.i. CFU count in the lungs of the challenged mice.
The infected mice were placed and manipulated in isolator in A3 protection-level facilities at
Institut Pasteur. One month later, the lungs and spleen of the infected mice were individually
homogenized by using a MillMixer organ homogenizer (Qiagen, Courtaboeuf, France). Serial
5-fold dilutions were plated on 7H11 Agar medium supplemented with ADC (Difco, Becton
Dickinson). The CFU were counted after 18–21 days of incubation at 37°C.
Statistical analyses
The statistical analyses were performed by use of GraphPad Prism software (GraphPad Soft-
ware, La Jolla, CA, USA) and Mann-Whitney test for simple comparison or One Way ANOVA
test with Tukey’s correction for multiple comparisons in order to determine the statistical sig-
nificance of obtained data.
Accession numbers
ID numbers for proteins mentioned in the text according to Tuberculist (http://genolist.
pasteur.fr/TubercuList/index.html)
ESAT-6, EsxA: Rv3875
CFP-10, EsxB: Rv3875
EspC: Rv3615c
PE18: Rv1788
PE19: Rv1791
PPE25: Rv1787
PPE26: Rv1789
PPE27: Rv1790
EccD5: Rv1795
Supporting Information
S1 Table. Immunogenic regions of ESX-5 associated PE19 and PPE25. PPE25- and PE19-d-
erived peptides, containing MHC-II, I-Ab-restricted T-cell epitopes, either highly specific to
Mtb esx-5 region (A) or shared by other PE/PPE homologs coded outside this region (B), as
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previously identified [5].
(TIF)
S1 Fig. The esx-1 and esx-5 genomic regions ofMtb and schematic representation of the
ESX-1 and ESX-5 T7SSs. (A) Genetic organization of the esx-1 and esx-5 genomic regions of
Mtb. (B) Schematic representation of ESX-1 and ESX-5 T7SSs which export/secret Esx and PE/
PPE proteins. Secretion of ESAT-6 and CFP-10 via ESX-1 is responsible of the induction of
specific T cells in immunized mice (B, left). Numerous PE/PPE proteins, either coded inside or
outside the esx-5 region, are exported/secreted via the trans-membrane EccD5 channel of the
ESX-5 system. Subsequent to immunization with theMtb Δppe25-pe19 strain, secretion of
numerous PE/PPE homologs coded outside esx-5 induces T cells, which via cross reactivity, are
able to recognize ESX-5-coded PE/PPE virulence-related factors.
(TIF)
S2 Fig. Induction of Th1 cytokine responses specific to esx-5-coded PPE25 and PE19 in
Mtb Δppe25-pe19- or WT-immunized mice. IL-2, TNF-α and IFN-γ production, as quanti-
fied by ELISA in the culture supernatants of splenocytes from C57BL/6 mice (n = 5 per group)
immunized s.c. with theMtb Δppe25-pe19 or theMtbH37RvWT strain and stimulated in vitro
with individual PPE25- and PE19-derived peptides, either highly specific to esx-5 or shared by
other PE/PPE proteins coded outside this region at 4 wks p.i. ESAT-6:1–20 or MalE:100–114
peptides were used respectively as positive or negative controls. Error bars represent SD. The
results are representative of two independent experiments.
(TIF)
S3 Fig. Results obtained with negative controls in cytometric analyses used to identify func-
tional Th1 subsets in the Fig 1A. Splenocytes from theMtb Δppe25-pe19-immunized C57BL/
6 mice shown in the Fig 1 were stimulated in vitro with the control MalE:100–114 (A) or
homologous peptide (B), prior to surface and intracellular staining with anti-cytokine mAbs
(A), or to intracellular staining with control Ig isotypes (B).
(TIF)
S4 Fig. Profile of Th1 cytokine-producing CD4+ T cells specific to individual esx-5-specific
PE/PPE epitopes in theMtbWT-immunized mice. (A-B) Th1 cytokine-producing splenic
CD4+ T effectors of C57BL/6 mice (n = 5) at 4 weeks after s.c. injection with 1 x 106 CFU/
mouse ofMtbWT strain, analyzed as detailed in the legend to the Fig 1. Such Th1 responses
against PE/PPE epitopes specific to esx-5 were not detected inMtb Δppe25-pe19-immunized
mice.
(TIF)
S5 Fig. Virulence of theMtb Δppe25-pe19 strain compared to the BCG Danish vaccine.
SCID mice were infected i.v. with 1 x 106 CFU/mouse of the BCG Danish 1331 vaccine or the
Mtb Δppe25-pe19 strain, as a selected TB vaccine candidate in an independent preclinical viru-
lence trial within the framework of the TBVAC2020 consortium. Control mice received saline
only. The weight loss kinetics was followed over a period of 90 days. Animals were euthanized
when they reached the human endpoint of>20% weight loss or showed severe clinical signs of
disease according to the UK Home Office guidelines referring to the welfare of experimental
animals. TheMtb Δppe25-pe19 strain displayed only a weakly higher degree of virulence, as
compared BCG Danish 1331, which is the most attenuated live TB vaccine [41, 42]. Work is
currently in progress to introduce in theMtb Δppe25-pe19 strain a second attenuating muta-
tion, which however preserves ESAT-6 secretion.
(TIF)
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S6 Fig. Differentiation status of the functional Th1 subsets in mice immunized with a syn-
thetic PPE25 peptide formulated in CpG(DOTAP). Splenocytes from mice immunized with
the representative PPE25:1–20 peptide, stimulated with the homologous peptide as detailed in
Materials and Methods, stained for the surface differentiation markers, and then by ICS, as
described in the Fig 1. Results are means ± SD of experimental duplicates.
(TIF)
S7 Fig. T-cell responses specific to PPE25 and PE19 epitopes in BCG-immunized mice. T-
cell IFN-γ responses of the splenocytes from C57BL/6 mice (n = 4) immunized s.c. with 1 x 106
CFU/mouse of BCG 1173P2 Pasteur strain, at 4 weeks p.i., subsequent to in vitro stimulation
with PPD, Ag85A:241–260, control MalE:100–114 peptide or individual PPE25- and PE19-d-
erived epitopes. The data are representative of two independent experiments.
(TIF)
S8 Fig. CD44 expression and numbers of lung CD4+ T cells recovered from immunized
mice. A, B) Expression of CD44 activation marker by the lung CD3+ CD4+ T cells in the
immunized or the control mice, as studied ex vivo at day 40 in (A) PE/PPE-immunized mice
(see Fig 7A) or (B) BCG-primed and PE/PPE-boosted mice, at day 90 (see Fig 8A and 8C)
Total numbers of lung CD4+ T cells, as determined at day 90 in the BCG-primed and PE/PPE-
boosted C57BL/6 mice (n = 6 per group), detailed in the legend to the Fig 8. These numbers
were determined as total numbers of cells in the Ficoll-treated lung fractions, multiplied by the
percentages of CD3+ CD4+ cells, as assessed by cytometry. NS = not significant,  or  = sta-
tistically significant, as determined by One Way ANOVA test with Tukey’s correction for mul-
tiple comparisons, p<0.005 or p<0.001, respectively.
(TIF)
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